Bambusa Therapeutics Inc. (BBTX) Stock Price & Fundamentals
Data as of Nov 16, 2026 (intraday, delayed) · Source: Financial Modeling Prep (methodology)
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company.
Valuation
Financials & Margins
Peer Comparison
Valuation & Return Ratios
Ownership
For Bambusa Therapeutics Inc., insiders hold 31.57% of the shares, institutions hold 32.60%, according to the latest holder filings.
Filings & documents
Bambusa Therapeutics Inc. (BBTX) reports filed with the US Securities and Exchange Commission, newest first. SEC CIK 0002044950. Links open sec.gov.
Recent events (8-K)
- Charter or bylaw amendment; Regulation FD disclosure8-K
Source: SEC EDGAR, checked 16 Nov 2026. All filings on SEC EDGAR
Latest News
About Bambusa Therapeutics Inc.
Bambusa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in developing a portfolio of next-generation, multi-targeting medicines designed to transform patient care across chronic immunology and inflammation diseases. The company was founded by Shan Shan Xu, Thang Ho, and Helmut Jeggle on March 14, 2024 and is headquartered in Boston, MA.
Bambusa Therapeutics Inc. is headquartered in US.
Bambusa Therapeutics Inc. (BBTX) stock trades at $16.21 with a market capitalization of $806.74M. Over the past 52 weeks the stock has ranged between $13.60 and $17.65, and currently trades 8.2% below its 52-week high.
Official website: www.bambusatx.com
Bambusa Therapeutics Inc. (BBTX) — frequently asked questions
What is Bambusa Therapeutics Inc. (BBTX) stock price today?
Bambusa Therapeutics Inc. (BBTX) is currently trading at $16.21, up 0.76% today.
What is Bambusa Therapeutics Inc.'s market cap?
Bambusa Therapeutics Inc. has a market capitalization of $806.74M.
What is BBTX's profit margin?
Bambusa Therapeutics Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is BBTX in?
Bambusa Therapeutics Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is BBTX listed on?
Bambusa Therapeutics Inc. trades on NASDAQ under the ticker BBTX.
What is BBTX's 52-week range?
Over the last year Bambusa Therapeutics Inc. has traded between $13.60 and $17.65.
Related Healthcare Stocks
Popular Stocks
Screens BBTX currently matches
On the figures above, Bambusa Therapeutics Inc. passes the filters for 4 of our ready-made screens, among them Small Cap Stocks, Stocks Under $100, Stocks Under $50. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.